Candidiasis Therapeutics Market Value Chain and Forecast 2016-2026
Candidiasis or commonly known as thrush is a fungal infection affecting men and women of all age groups. When thrush extends into the throat it causes esophagitis. It is also known by other names such as candidosis, moniliasis, and oidiomycosis. The effects of this infection are seen on a dermal, internal and systemic level wherein it is known as candidemia or intestinal thrush. The market is dynamic due to widespread occurrence of this disease, in particular as recurrent infections, limitations of safe and efficacious antifungals as well as the lack of reliable preventative approaches. The major drug classes for treatment include azoles, polyenes and echinocandins.Candidiasis Therapeutics Market: Drivers and Restraints
Increase in number of patients affected by candidiasis infection, increasing consumer inclination towards maintaining aesthetic appearance and growing awareness for candidiasis infection in developing markets are expected to boost the market growth over the forecast period. This is mainly due to urbanization and rising hygiene awareness in developing countries. Less R&D activity in this sector and availability of alternative treatments is expected to restraint the candidiasis therapeutics market over the forecast year. The factors such as narrow pipeline molecules and competition from herbal medicines and alternate therapies such as probiotic are expected to restrain the market growth over the forecast period.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1327
Candidiasis Therapeutics Market: Segmentation
Candidiasismarket is classified on the basis of route of administration, drug type, anatomy type and distribution channel:
Based on route of administration, the global candidiasis therapeutics marketcan be segmented as follows:
Injection
Ointment
Oral
Based on class of drugs, the global candidiasis therapeutics marketcan be segmented as follows:
Polyene
Azole
Echinocandin
Miscellaneou
Based on anatomy type, the global candidiasis therapeutics marketcan be segmented as follows:
Oral Candidiasis
Vulvovaginal Candidiasis
Cutaneous Candidiasis
Invasive Candidiasis
Systemic Candidiasis
Based on distribution channel, the global candidiasis therapeutics market can be segmented as follows:
Hospitals
Clinics
Retail Pharmacies
Drug Stores
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1327
Candidiasis Therapeutics Market: Overview
The global market for anti-candidiasis agents is expected to grow with a healthy CAGR over the forecast period. The market for systemic candidiasis is driven by increases in the susceptible immune compromised patient pool. Thrush occurs in approximately 2–5 percent of healthy new born and affect them mainly during their first year of life. Over 1 million adult women and adolescent girls in the U. S. develop vaginal yeast infections each year.
Candidiasis Therapeutics Market: Region-wise Outlook
Based on geographic regions, gastroesophageal reflux disease therapeutics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Japan, Asia Pacific and Middle East & Africa. The disease is growing globally and is not restricted to any particular region. North America and Europe region account for the largest markets revenue share due to higher awareness of the disease amongst individuals and also availability of better treatment. Asia-Pacific also offers considerable opportunities owing to low unmet need in this region.
Browse Full Report@ http://www.futuremarketinsights.com/reports/candidiasis-therapeutics-market
Candidiasis Therapeutics Market: Key Players
The anti-fungal candidiasis treatment is a highly fragmented mature market with a large number of generics. Major players in the market are Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy, Bristol Laboratories, Glenmark Pharmaceuticals, Taro Pharmaceuticals and Perrigo among many other local players. There are several types of formulations available for treatment based on the modality such as pills, powders, ointments and injectable. In 2013, Astellas Pharma reported positive results from its phase III drug isavuconazole which is one of the only first-in-class molecules expected to enter the market.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Candidiasis Therapeutics Market Value Chain and Forecast 2016-2026 here
News-ID: 352126 • Views: …
More Releases from Future Market Insights
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,…
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry…
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033.
The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable…
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute…
More Releases for Candidiasis
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with…
Candidiasis Therapeutic and Disease Pipeline Review H1
Summary
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash. It will usually be found in areas such as the groin, the folds of the buttocks, between the breasts, toes, or fingers, and in…
Develop business strategies Of Candidiasis - Pipeline Review, H1 2018
"The Report Candidiasis - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Candidiasis Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2018, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581036
Candidiasis is caused by infection with species of the…
Candidiasis - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H2 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the…
Candidiasis - Pipeline Review, H2 Pharmaceutical Research Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Candidiasis - Pipeline Review, H2 2017”. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a clearly defined patch of red, itchy skin, often leaking fluid. Scabs and pustules may be seen around the edge of the rash.
Request For…
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin…